• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位 21 岁的儿童期 Wilms 瘤幸存者,携带 BRCA1 2634delC 突变,发生乳腺癌。

Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutation.

机构信息

Virginia G. Piper Cancer Center, Scottsdale Healthcare, 10510 N. 92nd Street, Scottsdale, AZ 85258, USA.

出版信息

Clin Breast Cancer. 2011 Aug;11(4):268-9. doi: 10.1016/j.clbc.2010.11.001. Epub 2011 May 3.

DOI:10.1016/j.clbc.2010.11.001
PMID:21729660
Abstract

Breast cancer at age 21 is rare, even in individuals who have a genetic predisposition. These early diagnoses are usually the result of a hereditary cancer syndrome. Other contributing factors, such as chemotherapy and radiation for previous malignancies, can also increase the risk of secondary malignancies, including breast cancer. Here we present one of the youngest cases of breast cancer reported in the literature: a 21-year-old Wilms' tumor survivor (diagnosed at age 6), who was found to have a familial BRCA1 mutation and was diagnosed with ductal carcinoma in situ at age 21.

摘要

21 岁患乳腺癌极为罕见,即使患者有遗传易感性也是如此。这些早期诊断通常是遗传性癌症综合征的结果。其他促成因素,如先前恶性肿瘤的化疗和放疗,也会增加继发性恶性肿瘤(包括乳腺癌)的风险。在此,我们报告了文献中报道的最年轻的乳腺癌病例之一:一名 21 岁的 Wilms 瘤幸存者(6 岁时确诊),她被发现存在家族性 BRCA1 突变,并在 21 岁时被诊断为导管原位癌。

相似文献

1
Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutation.一位 21 岁的儿童期 Wilms 瘤幸存者,携带 BRCA1 2634delC 突变,发生乳腺癌。
Clin Breast Cancer. 2011 Aug;11(4):268-9. doi: 10.1016/j.clbc.2010.11.001. Epub 2011 May 3.
2
Breast cancer after radiation exposure in childhood.
N J Med. 1993 Mar;90(3):234-6.
3
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.青少年乳腺癌中的高危型人乳头瘤病毒感染、肿瘤表型特征、BRCA1/2 和 TP53 状态。
Breast Cancer Res Treat. 2010 Aug;122(3):671-83. doi: 10.1007/s10549-009-0596-6. Epub 2009 Oct 23.
4
High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.患有遗传性/家族性非BRCA1/BRCA2乳腺癌的女性对侧乳腺癌风险高。
Cancer. 2006 Mar 15;106(6):1237-42. doi: 10.1002/cncr.21753.
5
Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center.在一家学术医疗中心接受治疗的乳腺癌患者中基于模型的BRCA1/2突变状态预测。
Cancer. 2002 Jan 15;94(2):305-13. doi: 10.1002/cncr.10223.
6
Breast cancer following adjuvant radiotherapy of Wilms' tumor.肾母细胞瘤辅助放疗后发生的乳腺癌。
Wis Med J. 1983 Feb;82(2):26-7.
7
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者同侧乳腺癌的风险。
Breast Cancer Res Treat. 2011 May;127(1):287-96. doi: 10.1007/s10549-010-1336-7. Epub 2011 Jan 9.
8
Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.BRCA1/2 基因突变筛查引入后乳腺癌手术方式的变化:单中心 158 例突变携带者的回顾性队列分析。
Ann Surg Oncol. 2011 Mar;18(3):745-51. doi: 10.1245/s10434-010-1381-9. Epub 2010 Oct 23.
9
Secondary leukemia following successful treatment of Wilms' tumor.肾母细胞瘤成功治疗后继发性白血病。
Am J Pediatr Hematol Oncol. 1989 Summer;11(2):158-61.
10
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.

引用本文的文献

1
Breast cancer in an 18-year-old female: A fatal case report and literature review.18 岁女性乳腺癌:致死病例报告及文献复习。
Cancer Biol Ther. 2018 Jul 3;19(7):543-548. doi: 10.1080/15384047.2017.1416931.
2
Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study.女性威尔姆斯瘤幸存者的乳腺癌:来自全国威尔姆斯瘤后遗症研究的报告。
Cancer. 2014 Dec 1;120(23):3722-30. doi: 10.1002/cncr.28908. Epub 2014 Oct 27.